BIOTECH-ROOM2-L Archives

Moderated conference on GMOs in the pipeline, hosted by the FAO Biotechnology Forum in 2012

Biotech-Room2-L@LISTSERV.FAO.ORG

Options: Use Forum View

Use Monospaced Font
Show HTML Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
From:
Biotech-Mod2 <[log in to unmask]>
Reply To:
Biotech-Mod2 <[log in to unmask]>
Date:
Tue, 6 Nov 2012 13:05:17 +0100
Content-Type:
text/plain
Parts/Attachments:
text/plain (20 lines)
I am Adrian Dubock, project manager for Golden Rice (GR). (see www.goldenrice.org ). (GR does not include a selectable marker gene.)

I write to applaud Professor Pushpendra K Gupta's comment (Message 3) on the issue: very clearly stated and correct, from my understanding.

I think the question posed from Belgium (Message 2), and the response from India (Message 3) also illustrates well an important issue: it is long overdue to start basing decisions on scientific evidence: NOT on 'public opinion'. (Who are 'the public'? We all are.) Science and policy must be prepared to stand up to correct false information.

I believe that the European Regulators have come to the same decision as Prof Gupta with respect to antibiotic selectable markers.

Adrian C Dubock PhD
Golden Rice Project Manager
Switzerland
contact (at) goldenrice.org

[To contribute to this conference, send your message to [log in to unmask] For further information on this FAO Biotechnology Forum, see http://www.fao.org/biotech/biotech-forum/]

########################################################################

To unsubscribe from the Biotech-Room2-L list, click the following link:
https://listserv.fao.org/cgi-bin/wa?SUBED1=Biotech-Room2-L&A=1

ATOM RSS1 RSS2